What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge [Globe and Mail, The (Toronto, Canada)]
What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge [Yahoo! Finance]
Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wedbush from $53.00 to $58.00. They now have an "outperform" rating on the stock.
Kiniksa's Heart's Home Campaign Puts ARCALYST Growth Prospects In Focus [Yahoo! Finance]
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis [Yahoo! Finance]